Using Encala in Tube Feeding

Enrich your tube feeding regimen with the convenience and clinically proven medical benefits of Encala.

Encala is a medical food that can be added to your tube feeding formula.

Encala is:

  • Non-GMO
  • Plant-Based
  • Added to your existing tube feed formula
  • Contains Essential Fatty Acids

Do you want to fortify your current tube feeding regimen with highly absorbable long chain fats and enhance your caloric intake?

  • Encala is rich in essential fatty acids and choline, and is clinically proven to increase plasma levels of essential fatty acids, choline and fat soluble vitamins.1
  • Encala is clinically proven to increase fat absorption, improve BMI and height in only 3 months, and adds healthy calories to your diet.1
  • Encala also can improve your GI symptoms which may make you feel better, and improve your appetite.

You may benefit from including Encala in your regimen:

  • Encala improves fat and nutrient absorption without the need for lipase enzymes or bile acids.
  • Adding healthy fats to your diet with Encala can improve your overall health.
  • Encala is added to meals and snacks to increase healthy calories and reinforce success with oral feeding.
  • Improvement in appetite is often seen when GI symptoms are reduced.
  • Increasing the amount of fat you absorb with Encala encourages healthy metabolism and is believed to increase weight and height.3
  • Studies have demonstrated that up to 25% of patients on PERT still have inadequate fat absorption which undermines their nutritional goals.4
  1. Stallings VA, Tindall AM, Mascarenhas MR, Maqbool A, Schall JI. Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a novel oral structured lipid supplement: a randomized controlled trial. PLoS One. 2020;15(5):e0232685. View the study.
  2. Kalivianakis, Minich, Bijleveld, et al., Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids, The American Journal of Clinical Nutrition, Volume 69, Issue 1, January 1999, Pages 127–134. View the study.
  3. Stallings, Schall, Maqbool, et al., Effect of Oral Lipid Matrix Supplement on Fat Absorption in Cystic Fibrosis: A Randomized Placebo-Controlled Trial. J Pediatr Gastroenterol Nutr. 2016;63(6):676-680. doi:10.1097/MPG.0000000000001213. View the study.
  4. Woestenenk, Janna W., Cornelis K. van der Ent, and Roderick HJ Houwen. “Pancreatic enzyme replacement therapy and coefficient of fat absorption in children and adolescents with cystic fibrosis.” Journal of pediatric gastroenterology and nutrition 61.3 (2015): 355-360. View the study.
Scroll to Top